Screening for gestational diabetes by measuring fasting plasma glucose levels

Area of Science:

• Endocrinology
• Obstetrics
• Clinical Chemistry

Background:

• Gestational diabetes mellitus (GDM) poses risks to both mother and fetus.
• Accurate and efficient screening methods for GDM are crucial in prenatal care.
• Current screening often involves multiple tests, which can be burdensome for patients.

Purpose of the Study:

• To evaluate the diagnostic accuracy of fasting plasma glucose (FPG) levels for GDM screening.
• To compare the effectiveness of FPG screening against the one-hour glucose challenge test (GCT) for GDM prediction.

Main Methods:

• 1600 pregnant women were screened using the GCT and FPG tests during 26-32 weeks gestation.
• Diagnostic oral glucose tolerance tests (oGTT) were performed on all participants.
• Receiver-operating characteristic (ROC) curves were utilized to determine optimal cutoff values for FPG and oGTT.

Main Results:

• An FPG cutoff of ≥ 5.5 mmol/L demonstrated high sensitivity (94%) and specificity (93%) for GDM.
• FPG screening required a diagnostic oGTT in 32% of cases, compared to 13% with GCT.
• The GCT identified a GDM incidence of 13.5% using established cutoff values.

Conclusions:

• Fasting plasma glucose (FPG) at a cutoff of ≥ 5.5 mmol/L is a highly sensitive and specific screening tool for GDM.
• FPG offers a simpler, more patient-acceptable, and cost-effective alternative to the GCT.
• Implementing FPG screening can significantly reduce the need for diagnostic oGTTs, improving patient compliance and healthcare efficiency.